DMIIU NASDAQ
Drugs Made In America Acquisition II Corp. Unit
1W: +0.4%
1M: +0.7%
3M: +0.7%
YTD: +1.5%
$10.15
+0.01 (+0.05%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$706.2M
52W Range9.935-10.8
Volume1,500
Avg Volume3,295
Beta0.05
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORoger Bendelac
Employees2
SectorFinancial Services
IndustryAsset Management
IPO Date2025-09-25
Websitedmaacorp.com/
1 East Broward Boulevard
Fort Lauderdale, FL 33301
US
Fort Lauderdale, FL 33301
US
954 870 3099
About Drugs Made In America Acquisition II Corp. Unit
A SPAC (blank check company) incorporated in the Cayman Islands to pursue a business combination. The company aims to focus on pharmaceutical / drug sector targets to reduce U.S. reliance on global drug manufacturing. Each unit consists of one ordinary share and one right to receive one-tenth of a share upon completion of a qualifying business combination.
Latest News
No recent news
Recent Insider Trades
No insider trades found